Close
Smartlab Europe
Achema middle east

News

Amgen to acquire privately held KAI Pharmaceuticals

Amgen (NASDAQ: AMGN) and KAI Pharmaceuticals today announced an agreement under which Amgen will acquire KAI, a privately held pharmaceutical company based in South San Francisco. KAI's lead product candidate, KAI-4169, is a novel...

Indian government to address pharma industry issues

The task force, set up by the Union health ministry in India, has recommended the adoption of SMS model and identification code as a suitable method for the track and trace system. The system...

Purdue Pharma announces availability of insomnia drug

Purdue Pharma has announced the availability of Intermezzo sublingual tablet CIV in 1.75mg and 3.5mg dosage strengths for insomnia characterized by middle-of-the-night awakenings followed by difficulty returning to sleep. Intermezzo (zolpidem tartrate), which contains...

VitalMax unveils advanced vitamin formula to maintain glucose levels

VitalMax Vitamins, a nutritional supplement company, has introduced Diabetrol, an advanced vitamin formula to keep glucose levels in check. Diabetrol consists of 16 natural vitamin ingredients, formulated to help provide blood sugar protection. The advanced...

PolyTherics joins Spirogen to develop antibody-drug conjugates

PolyTherics has executed a research collaboration deal with Spirogen to develop antibody-drug conjugates (ADCs) for the treatment of cancer. Under the collaboration, the companies will produce ADCs by integrating PolyTherics' proprietary TheraPEG linker technology...

Scientists map new mechanism in brain’s barrier tissue

Researchers at the University of Copenhagen have documented a previously unknown biological mechanism in the brain's most important line of defence: the blood-brain barrier. Scientists now know that the barrier helps maintain a delicate balance of glutamate, a...

IMI funds platform to discover new medicines

The Innovative Medicines Initiative has officially announced the construction of an EU-wide public-private partnership, the "European Lead Factory", to combine a comprehensive collection of candidate drug molecules - a Joint European Compound Collection - with an industry-like European...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »